Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

BACKGROUND: Cell-free DNA (cfDNA) genotyping in plasma using the cobas EGFR Mutation Test v2 (cobas) is the first liquid biopsy as a companion diagnosis to identify the EGFR T790M mutation (T790M) after the failure of treatment of EGFR-tyrosine kinase inhibitors (TKIs) (1st generation, gefitinib [G]...

Descripción completa

Detalles Bibliográficos
Autores principales: Oya, Yuko, Yoshida, Tatsuya, Asada, Kazuhiro, Oguri, Tetsuya, Inui, Naoki, Morikawa, Sayako, Ito, Kentaro, Kimura, Tomoki, Kunii, Eiji, Matsui, Takashi, Kubo, Akihito, Kato, Tatsuo, Abe, Takashi, Tsuda, Takeshi, Hida, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802126/
https://www.ncbi.nlm.nih.gov/pubmed/33435905
http://dx.doi.org/10.1186/s12885-020-07777-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802126/
https://www.ncbi.nlm.nih.gov/pubmed/33435905
http://dx.doi.org/10.1186/s12885-020-07777-2

Ejemplares similares